Abstract:The development of safe and effective medications requires a profound understanding of their pharmacokinetic (PK) and pharmacodynamic properties. PK studies have been built through investigation of enzymes and transporters that drive drug absorption, distribution, metabolism, and excretion (ADME). Like many other disciplines, the study of ADME gene products and their functions has been revolutionized through the invention and widespread adoption of recombinant DNA technologies. Recombinant DNA technologies use expression vectors such as plasmids to achieve heterologous expression of a desired transgene in a specified host organism. This has enabled the purification of recombinant ADME gene products for functional and structural characterization, allowing investigators to elucidate their roles in drug metabolism and disposition. This strategy has also been used to offer recombinant or bioengineered RNA (BioRNA) agents to investigate the posttranscriptional regulation of ADME genes. Conventional research with small noncoding RNAs such as microRNAs (miRNAs) and small interfering RNAs has been dependent on synthetic RNA analogs that are known to carry a range of chemical modifications expected to improve stability and PK properties. Indeed, a novel transfer RNA fused pre-miRNA carrier-based bioengineering platform technology has been established to offer consistent and high-yield production of unparalleled BioRNA molecules from Escherichia coli fermentation. These BioRNAs are produced and processed inside living cells to better recapitulate the properties of natural RNAs, representing superior research tools to investigate regulatory mechanisms behind ADME. SIGNIFICANCE STATEMENT This review article summarizes recombinant DNA technologies that have been an incredible boon in the study of drug metabolism and PK, providing investigators with powerful tools to express nearly any ADME gene products for functional and structural studies. It further overviews novel recombinant RNA technologies and discusses the utilities of bioengineered RNA agents for the investigation of ADME gene regulation and general biomedical research.

Recombinant CBM-fusion technology - Applications overview

[Newly Progress in Applications of Saccharomyces Cerevisiae Cell-Surface Engineering].

Functionalization of Cellulose-Based Hydrogels with Bi-Functional Fusion Proteins Containing Carbohydrate-Binding Modules

Applications of novel affinity cassette methods: use of peptide fusion handles for the purification of recombinant proteins

Expression of Family 3 Cellulose-Binding Module (cbm3) As an Affinity Tag for Recombinant Proteins in Yeast

A novel protein fusion partner, carbohydrate-binding module family 66, to enhance heterologous protein expression in Escherichia coli

Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research

Recombinant protein expression and purification: A comprehensive review of affinity tags and microbial applications

Biofunctionalization of Cellulose Microcarriers Using a Carbohydrate Binding Module Linked with Fibroblast Growth Factor for the Expansion of Human Umbilical Mesenchymal Stromal Cells in Stirred Suspension Bioreactors

Biotechnology Applications of Cell-Free Expression Systems

Methods for recombinant expression and functional characterization of human cannabinoid receptor CB2

Non-covalent binding tags for batch and flow biocatalysis

Protein Immobilization on Bacterial Cellulose for Biomedical Application

Engineering and characterization of carbohydrate-binding modules for imaging cellulose fibrils biosynthesis in plant protoplasts

Harnessing cellulose-binding protein domains for the development of functionalized cellulose materials

Genetic Functionalization of Protein-Based Biomaterials via Protein Fusions

Purification of a recombinant protein with cellulose-binding module 3 as the affinity tag.

Multifunctional cellulase catalysis targeted by fusion to different carbohydrate-binding modules

Recombineering BAC transgenes for protein tagging

Role of Recombinant DNA Technology to Improve Life

A systematic review about affinity tags for one-step purification and immobilization of recombinant proteins: integrated bioprocesses aiming both economic and environmental sustainability